Unknown

Dataset Information

0

Suppression of CLC-3 chloride channel reduces the aggressiveness of glioma through inhibiting nuclear factor-?B pathway.


ABSTRACT: CLC-3 chloride channel plays important roles on cell volume regulation, proliferation and migration in normal and cancer cells. Recent growing evidence supports a critical role of CLC-3 in glioma metastasis, however, the mechanism underlying is unclear. This study finds that CLC-3 is upregulated in glioma tissues and positively correlated with WHO histological grade. Patients with high CLC-3 expression had an overall shorter survival time, whereas patients with low expression of CLC-3 had a better survival time. Silencing endogenous CLC-3 with ShCLC-3 adenovirus significantly decreases volume-regulated chloride currents, inhibits the nuclear translocation of p65 subunit of Nuclear Factor-?B (NF-?B), decreases transcriptional activity of NF-?B, reduces MMP-3 and MMP-9 expression and decreases glioma cell migration and invasion. Taken together, these results suggest CLC-3 promotes the aggressiveness of glioma at least in part through nuclear factor-?B pathway, and might be a novel prognostic biomarker and therapeutic target for glioma.

SUBMITTER: Wang B 

PROVIDER: S-EPMC5609961 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Suppression of CLC-3 chloride channel reduces the aggressiveness of glioma through inhibiting nuclear factor-κB pathway.

Wang Bing B   Xie Jing J   He Hai-Yong HY   Huang En-Wen EW   Cao Qing-Hua QH   Luo Lun L   Liao Yong-Shi YS   Guo Ying Y  

Oncotarget 20170708 38


CLC-3 chloride channel plays important roles on cell volume regulation, proliferation and migration in normal and cancer cells. Recent growing evidence supports a critical role of CLC-3 in glioma metastasis, however, the mechanism underlying is unclear. This study finds that CLC-3 is upregulated in glioma tissues and positively correlated with WHO histological grade. Patients with high CLC-3 expression had an overall shorter survival time, whereas patients with low expression of CLC-3 had a bett  ...[more]

Similar Datasets

| S-EPMC23874 | biostudies-literature
| S-EPMC2556891 | biostudies-literature
| S-EPMC6483157 | biostudies-literature
| S-EPMC6672451 | biostudies-literature
| S-EPMC4156679 | biostudies-literature
| S-EPMC8222222 | biostudies-literature
| S-EPMC6019066 | biostudies-literature
| S-EPMC4177969 | biostudies-literature
| S-EPMC2778193 | biostudies-literature
| S-EPMC5007535 | biostudies-literature